Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07555574 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Defining Retinal Structures Using Hyperspectral Retinal Imaging

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study evaluates hyperspectral retinal imaging as a novel, non-invasive imaging technique to characterise retinal and optic nerve structures in healthy individuals and patients with eye disease. Hyperspectral imaging captures retinal data across multiple wavelengths to generate detailed spectral information that may reveal features not visible with conventional retinal photography. Approximately 1000 participants will undergo multi-modal ophthalmic imaging in Melbourne, Australia, including hyperspectral imaging, OCT, fundus photography, and related tests. The study aims to compare hyperspectral imaging with standard imaging methods and assess its ability to identify retinal biomarkers associated with diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration.
Trial Details
NCT Number NCT07555574
Lead Sponsor Center for Eye Research Australia
Conditions
(from sponsor)		 Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Diseases, Healthy Volunteers
Related terms Diabetic Retinopathy, Glaucoma, Macular Degeneration, Retinal Diseases
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov